Core Scientific, Inc./tx (CORZR) Asset Writedowns and Impairment (2022 - 2026)

Core Scientific (CORZR) has 4 years of Asset Writedowns and Impairment data on file, last reported at $266.5 million in Q1 2026.

• For the quarter ending Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $266.5 million; the trailing twelve-month figure through Mar 2026 stood at $277.8 million (changed N/A YoY), and the FY2025 full-year result was $11.4 million, changed N/A from the prior year.
• Asset Writedowns and Impairment improved to $266.5 million in Q1 2026, from $11.4 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $790.8 million in Q2 2022 to a low of -$784.8 million in Q3 2022.
• A 4-year average of $41.0 million and a median of $11.4 million in 2025 frame the typical range for Asset Writedowns and Impairment.
• Peak annual rise in Asset Writedowns and Impairment reached 111.68% in 2025, while the deepest fall reached 111.68% in 2025.
• Tracing CORZR's Asset Writedowns and Impairment over 4 years: stood at $3.1 million in 2022, then sank by 3277.43% to -$97.3 million in 2024, then soared by 111.68% to $11.4 million in 2025, then surged by 2246.05% to $266.5 million in 2026.
• Business Quant data shows CORZR's Asset Writedowns and Impairment at $266.5 million in Q1 2026, $11.4 million in Q4 2025, and -$97.3 million in Q4 2024.